Skip to main content
Danielle Antin-Ozerkis, MD, Pulmonology, North Haven, CT, Yale-New Haven Hospital

DanielleElyseAntin-OzerkisMD

Pulmonology North Haven, CT

Critical Care Medicine

Associate Professor, Internal Medicine, Yale University School of Medicine

Telehealth Available

Overview of Dr. Antin-Ozerkis

Dr. Danielle Antin-Ozerkis is a pulmonologist in North Haven, CT and is affiliated with Yale-New Haven Hospital. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 18 years. Dr. Antin-Ozerkis accepts several types of health insurance, listed below. She is one of 163 doctors at Yale-New Haven Hospital who specialize in Pulmonology. She has more than 30 publications and over 500 citings.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2006
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1999

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2006 - 2024
  • PA State Medical License
    PA State Medical License 2000 - 2006
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • 2023 ‘Top Doctors’ List Features Over 250 Yale Medicine Physicians
    2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
  • Following Computational Predictions, Scientists Demonstrate That Cancer Drug Counters Pulmonary Fibrosis
    Following Computational Predictions, Scientists Demonstrate That Cancer Drug Counters Pulmonary FibrosisSeptember 1st, 2022
  • Saracatinib as Effective, or Superior to Ofev, Esbriet in IPF Models: Study
    Saracatinib as Effective, or Superior to Ofev, Esbriet in IPF Models: StudyAugust 30th, 2022
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Connecticare FlexPOS
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment